Slide 1: Q1 2016 Earnings Conference Call
Q1 2016 EARNINGS* Conference Call May 26 at 6:15pm CET * Not audited
Slide 2: Safe Harbor Statement
SAFE HARBOR STATEMENT This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward-looking statements involve risk and uncertainty. Forward-looking statements represent the compa
Slide 3: An innovative technology and services company
a cegedim An innovative technology and services company In 2015 Iw So = UNITED KINGDOM hae Cegedim Insurance Solutions / Cegedim RX / Cegedim SRH / INPS / Webstar SWITZERLAND €42 6 m UNITED STATES FRANCE coscnsie Pulse . a 2 of revenue ROMANIA Cegedim RX cdl 3,600 employees 1] countries TUNISIA Next
Slide 4: Our Clients
x Our Clients Gy, Physicians 4 vet ry" Hea alincare Pharmacists 4 al Paramedics, 40 million | Payers « Ss 7 All industries we Ss 7 . | , 100,000 }
Slide 5: Our business
x Our business 220,000 «| - Software - Database fa’ 7 | Servi 4l, y 83,000 _< : ee 000 VE, - Software - Database - Software - Services - Database - Supply chain - Services - Digital media SS ve Healthcare Ka y SS S L_/ \ \ Pharma } all major* ¢ I 40 million’¢ 165 million « invoices** - Software 1 ,0
Slide 6: Our divisions
< Our divisions « Health Insurance, H.R. & e-services Healthcare Professionals -o-s \ 40 million | Hospitals 4 Physicians 4 Pharma _¢ iF Gy Paramedics ¢ over 200 aE Pharmacists, e-business y 659.7m 552% a
Slide 7: Our R&D
< QOurR&D_ ~~ Sy Capitalized R&D a €9.1m as of March 2016 +54% change between March 2015 and March 2016 NF Revenue on Capitalized R&D Ratio re S 8.6% as of March 2016 +268 bps change between March 2015 and March 2016
Slide 8: Our Positions
< Our Positions ~ ee Cegedim Insurance Solutions of a a #1 #1 Sofware and IT Third-Party Payment in France in France \ 4 Cegedim e-business i — a » #1 +300 million in 2015 Electronic Documents exchanged per year European Network — Cegedim SRH 4 * a SS #2 +40,000 in 2013 in France +50,000 in 2014 Acq
Slide 9: Our Strengths
x ne Leading market positions in each of our divisions a NN 4 High barriers to entry io = A a Recognized portfolio of innovative and integrated solutions a Our Stengths é= x ee Stable, well-balanced and diversified revenue mix , NS £ Unique presence in the Healthcare Ecosystem 4 ™ x N a Long-standin
Slide 10: Business Group Review
Business Group Review m cegedim
Slide 11: Roadmap for Profitable and Sustainable Growth
Roadmap for Profitable and Sustainable Growth 2018 • Full benefit of Group transformation • Well positioned for 2016 - 2017 coming years • Group Transformation 2015 - Management • Disposal of the CRM evolution and Strategic Data - Organization change division - Change in business • Acquisition of Ac
Slide 12: Cegedim Investments
Cegedim Investments Product Update SaaS / Cloud BPO • Upgrades to • All new solutions will • Process efficiency reflects market be Cloud based • Flexibility in scaling changes • Will reduce cost of • Trends toward more development, outsourcing • Introduce new offer maintenance and production • Drive
Slide 13: Q1-2016 Financial Situation
Q1-2016 Financial Situation
Slide 14: Key Figures, Key Points, Outlook
Key Figures Key Points Outlook Revenue Group offering Interest expense €106.2m shifting to the cloud will reduce by +5.7% reported around 9 times +4.8% L-f-L Group Cloud and over the final 9M BPO offerings of 2016 EBITDA a success €11.1m Revenue up (24.6)% For 2016 Cegedim Margin impacted expects: E
Slide 15: Q1-16 Revenue Growth
Q1-16 Revenue Growth Division Q1-15 L-f-L Structure Currency Reported Q1-16 Health Insurance H.R. & e-services 53.7 +8.7% +2.5% +0.0% +11.2% 59.7 Healthcare Professionals 45.9 +0.5% — (1.0)% (0.5)% 45.7 Activities not 0.8 n.m. — — (3.8)% 0.8 allocated Cegedim 100.5 +4.8% +1.3% (0.5)% +5.7% 106.2 15
Slide 16: Well Diversified Revenue Sources
Well Diversified Revenue Sources 16
Slide 17: Q1-2016 P&L
Q1-2016 P&L In € million Q1-16 Q1-15 % Change Revenue 106.2 100.5 +5.7 EBITDA 11.1 14.7 (24.6)% margin 10.4% 14.6% (420)bps D&A (8.1) (7.3) +10.7% EBIT before special items 3.0 7.4 (59.4)% margin 2.8% 7.4% (454)bps Special items (1.1) (2.9) (62.0)% EBIT 1.9 4.6 (57.9)% margin 1.8% 4.5% (273)bps Cost
Slide 18: P&L by Division
P&L by Division Health Insurance Healthcare Activities not H.R. & e-services Professionals allocated Q1 16 Q1 15 Δ% Q1 16 Q1 15 Δ% Q1 16 Q1 15 Δ% Revenue 59.7 53.7 +11.2% 45.7 45.9 (0.5)% 0.8 0.8 n.m. EBITDA 7.1 8.5 (16.7)% 5.0 6.4 (22.0)% (1.0) (0.2) n.m. D&A (3.6) (3.9) (7.6)% (3.2) (2.9) +10.7% (
Slide 19: Health Insurance, H.R. & e-services
Health Insurance, H.R. & e-services Revenue +8.7% l-f-l EBITDA (16.7)% • Double digit growth at • Temporary decline in profitability at: • Cegedim Insurance Solutions despite • iGestion and Cegedim e-business the transition to the SaaS/Cloud due to the start of business with • iGestion, BPO activiti
Slide 20: Healthcare Professionals
Healthcare Professionals +0.5% l-f-l Revenue EBITDA (22.0)% • Growth of more than 60% at Pulse Systems • Decline due to investment made to owing to a successful rollout of its RCM ensure future growth offering and EHR offering • Chiefly by the investment done for the cloud software for French pharma
Slide 21: Managing the debt profile
Managing the debt profile New RCF facility of €200m with a 5 years maturity. Signed on January 2016. Shareholder loan: maturity extended to Jan. 2021. 6.75% bond 2020: Full redemption done on Q1 2016. 21
Slide 22: Consolidated Balance Sheet (in €m)
Consolidated Balance Sheet (in €m) Assets Mar. 16 Dec. 15 Goodwill 185.8 188.5 Other non-current assets 226.3 223.7 Cash & cash equivalents 20.2 231.3 Other current assets 233.1 220.0 Assets held for sale 1.4 0.8 Shareholders Equity & Liabilities Shareholders Equity(1) 200.0 228.1 Other non-current
Slide 23: Net Debt Situation
Net Debt Situation (1) Net total debt include liabilities under our employee profit sharing plans for €8,3m on March 31,2016 and for €8.3m on December 31, 2015 (2) Paid for the total redemption of the 6,75% bond maturing in 2020 23
Slide 24: Solid Capital Structure
Solid Capital Structure Credit Rating Corporate and capital structure Assessed on April 28, 2016 Maturity Profile This includes 0.3% of the shares of Cegedim S.A. held by Cegedim S.A. as of March 31, 2016 24
Slide 25: Outlook
Outlook Group transformation continue Robust investment in R&D maintained for 2016 Transition to SaaS and BPO deployment For 2016, Cegedim expects(1) at least stable revenue from continuing activities and stability at the EBITDA level. (1) These projections are publicly disclosed on May 26, 2016. th
Slide 26: Appendix
Appendix
Slide 27: Cegelease activity has evolved
Cegelease activity has evolved: In 2001 In 2015 Exclusive reseller of Group’s products Broker of financial leases Cegedim: unique supplier Many different suppliers Financing solutions for all healthcare Payment solution for Pharmacist professionals and others professionals Majority of contract are r
Slide 28: Q1 2015 Revenue Restatement by Division
Q1 2015 Revenue Restatement by Division Reported Restatement Restated Mar. 2015 Mar. 2015 Health Insurance H.R. & e-services 54.0 (0,3)(1) 53.7 Healthcare Professionals 37.2 8.7 45.9 Cegelease 29.3 (29.3) — Activities not allocated 0.8 — 0.8 Cegedim 121.3 (20.8) 100.4 (1) Cegedim Kadrige restatement
Slide 29: Cegelease's Restatement Impact
Cegelase’s Restatement Impact This leads to a restatement of Q1 2015 accounts in accordance with IAS 17. Impact on Revenue, EBITDA but not on EBIT In € million Q1 2015 Revenue 121.0 100.5 EBITDA 18.3 14.7 EBIT 7.3 7.4 before special items Before / After Restatement 29
Slide 30: We welcome your questions and comments
We welcome your questions and comments Jan Eryk Umiastowski Chief Investment Officer – Head of Investor Relations janeryk.umiastowski@cegedim.com Tel: 00 33 1 49 09 33 36 – Mob: 00 33 6 73 25 96 34